2012
DOI: 10.1016/j.arbr.2012.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Pleural Mesothelioma Secondary to Radiotherapy: A Rare Association

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…In this issue, Nakashima, et al reported the first Japanese case of malignant pleural mesothelioma (MPM) that developed 25 years after thoracic radiotherapy for Hodgkin's lymphoma without a history of asbestos exposure (1). A table of 29 similar cases in the literature (Table 1) ( [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] shows distinguishing features, which are summarized as follows: 1) women accounted for 55% of cases, which is much higher than the proportion of women who develop asbestosrelated MPM (<20%); 2) the median age at the diagnosis of MPM was 44 years old, whereas asbestos-related MPM is usually diagnosed in the late 50s or older (20); 3) 66% of patients had received radiotherapy for their first malignant tumor before 30 years old; and 4) the median period of latency was 16 years, which was shorter than the median period from the initial asbestos exposure to death of MPM (estimated to be ! 32 years) (21,22).…”
mentioning
confidence: 99%
“…In this issue, Nakashima, et al reported the first Japanese case of malignant pleural mesothelioma (MPM) that developed 25 years after thoracic radiotherapy for Hodgkin's lymphoma without a history of asbestos exposure (1). A table of 29 similar cases in the literature (Table 1) ( [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] shows distinguishing features, which are summarized as follows: 1) women accounted for 55% of cases, which is much higher than the proportion of women who develop asbestosrelated MPM (<20%); 2) the median age at the diagnosis of MPM was 44 years old, whereas asbestos-related MPM is usually diagnosed in the late 50s or older (20); 3) 66% of patients had received radiotherapy for their first malignant tumor before 30 years old; and 4) the median period of latency was 16 years, which was shorter than the median period from the initial asbestos exposure to death of MPM (estimated to be ! 32 years) (21,22).…”
mentioning
confidence: 99%